Literature DB >> 26818664

Anal Squamous Cell Carcinoma: An Infrequent Challenge in the Management of Ulcerative Colitis Under Combination Therapy.

Paulo Gustavo Kotze1, Patricia Zacharias2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26818664      PMCID： PMC4957460          DOI： 10.1093/ecco-jcc/jjw027

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  4 in total

1.  European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.

Authors:  Vito Annese; Laurent Beaugerie; Laurence Egan; Livia Biancone; Claus Bolling; Christian Brandts; Daan Dierickx; Reinhard Dummer; Gionata Fiorino; Jean Marc Gornet; Peter Higgins; Konstantinos H Katsanos; Loes Nissen; Gianluca Pellino; Gerhard Rogler; Franco Scaldaferri; Edyta Szymanska; Rami Eliakim
Journal:  J Crohns Colitis       Date:  2015-08-20       Impact factor: 9.071

Review 2.  A systematic review of anal squamous cell carcinoma in inflammatory bowel disease.

Authors:  A A P Slesser; A Bhangu; M Bower; R Goldin; P P Tekkis
Journal:  Surg Oncol       Date:  2013-08-26       Impact factor: 3.279

3.  Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005.

Authors:  Kåre G Sunesen; Mette Nørgaard; Ole Thorlacius-Ussing; Søren Laurberg
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

4.  Anal carcinoma in inflammatory bowel disease.

Authors:  M Frisch; C Johansen
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.